Targeted Medical Pharma Completes Promotion and Distribution Agreement for Clearwayz™

Promotion in Several Major Markets Using Direct-Response Commercials

Business Wire

LOS ANGELES--(BUSINESS WIRE)--

Targeted Medical Pharma, Inc. (TRGM), reported today on the completion of a promotion and distribution agreement with As Seen on TV Productions, a division of East Shore Enterprises, a company which specializes in brand promotion using Direct-Response television commercials and internet promotion for select audiences in major markets.

The non-exclusive agreement provides a platform for Clearwayz to connect to a wider consumer base through online and television advertising. Clearwayz is a dietary supplement specially formulated to support healthy sinus, respiratory and immune function using a proprietary blend of amino acids and polyphenols.

"Clearwayz offers a natural, drug-free option to people who are struggling with sinus and respiratory problems related to the cold, flu, or allergies and are concerned about the side effects of drugs,” said William Shell, M.D. CEO and Chief Science Officer of Targeted Medical Pharma, Inc. “This agreement will introduce this unique product into a broader marketplace, helping to build a sustainable sales channel for the dietary supplement division of the Company.”

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz™. The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.

Follow us on Twitter

Learn more on Facebook

Forward Looking Statement

This press release may contain forward-looking statements related to Targeted Medical Pharma’s business strategy, outlook, objectives, plans, intentions or goals. The words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Actual results could differ materially. Targeted Medical Pharma expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.

Contact:
Targeted Medical Pharma
Marcus Charuvastra, 310-474-9809
marcusch@tmedpharma.com
or
Investor Contact:
ProActive Capital Group
Jeff Ramson, 646-863-6893
ramson@proactivecapital.com


Rates

View Comments (0)